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ABSTRACT
Background: Cancer regisries worldwide have evolved to provide useful information 
on the burden and diversity of the patterns of cancer, information that is vital for 
establishing appropriate programmes for disease management. Population based data 
on cancer in western Kenya as captured in the Eldoret cancer registry established in 
1999 is analysed and reported in this paper. 
Objective: To determine the burden and pattern of cancer in Western Kenya by use of 
data from the Eldoret cancer registry.
Design: Retrospective study.
Setting: The cancer registry located in the Department of Haematology at the Moi 
University, School of Medicine situated at the Moi Teaching and Referral Hospital, 
Eldoret, Kenya. The hospital has a catchment population of 13 to 15 million people 
forming about 40% of the Kenyan population. 
Results: A total of 5,366 patients were diagnosed to have cancer and attended to at the 
MTRH and other hospitals in Eldoret during the period between January 1999 and 
December 2006 giving an average of 671 cases per year. Among those treated 2,699 were 
males and 2,667 were females giving a M: F ratio of 1:1. About 21% of the patients had 
haematological malignancies with non-Hodgkins lymphoma being the most common. 
Another 79% of the patients had solid tumours with cancer of the oesophagus being 
the commonest. Cancer of the cervix and prostrate were the commonest among the 
females and males respectively. A general increase in the number of patients with 
Kaposis sarcoma associated with HIV/AIDS pandemic was observed. 
Conclusion: The burden of cancer is a significant health problem in western Kenya 
and there is need for the development of a comprehensive cancer care programme in 
the region to address the growing problem. 
INTRODUCTION
Cancer is a worldwide disease and one of the 
leading causes of morbidity and mortality in the 
developed world where the burden of disease is 
accurately determined. In the developing countries, 
determination of the burden and pattern has not 
reached the same level as is the case in the west. 
Projections indicate an expected yearly incidence of 15 
to 20 million new cases worldwide with a staggering 
50 to 60% occurring in the developing world (1-4). To 
handle this expected epidemic, adequate information 
on burden and pattern of cancer needs to be available 
in order to promote effective decision making.
 Knowledge on cancers in Africa is unfortunately 
very scanty (5). Cancer as a disease entity has not 
been given the attention it deserves hence the limited 
knowledge. Until recently, available information 
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was based on hospital reviews by clinicians and 
pathologists (6). The need to embrace and manage 
population based registries is therefore self evident. 
Information generated from such registries will be 
important in planning and setting up programmes 
in cancer management. 
 The Eldoret cancer registry was established 
in 1999 and uses the active case finding approach 
from hospital records, pathology reports and death 
certificates in MTRH and other hospitals within 
the Uasin Gishu district to identify and register 
cancer cases. A significant proportion of patients are 
referrals from hospitals in the greater western Kenya 
region. Secondary data reviewed from this registry 
therefore provides information on the burden and 
pattern of cancer in western Kenya. It is not clear 
what proportion is captured but it gives an estimated 
burden in the catchment region which hosts about 
40% of the Kenyan population. 
MATERIALS AND METHODS
Secondary data from the Eldoret Cancer Registry 
located in the Department of Haematology at the 
Moi University School of Medicine located at the 
Moi Teaching and Referral Hospital, Eldoret were 
reviewed. 
 A pathologist is in charge of the registry which has 
a registrar and secretary as full time staff and engages 
Health Information and Records officers who collect 
the information from the hospital records department, 
pathology department, in-patient wards, the Eldoret 
Hospice and also from death certificates. Cases are 
identified from the disease index (completed by 
records staff in ICD-10) and details of cases abstracted 
from case records. Cases are coded in the registry and 
data entry and management done by the CANREG-3 
system, a software developed by IARC and designed 
for population based cancer registries. 
 The frequency and pattern of distribution 
of the cases of cancer was determined and 
classification done. The types of cancer were 
broadly classified into haematological and non-
haematological (solid tumours) malignancies. The 
haematological malignancies include Hodgkins 
and non-Hodgkins lymphoma, acute as well as 
chronic leukemia and others like multiple myeloma, 
plasmacytoma, myelopdysplastic syndrome and 
essential thrombocytosis. The solid tumours or 
non-haematological malignancies include cancers of 
various organs like the brain, thyroid, oesophagus, 
stomach, kidneys, cervix, skin, bone and muscle. 
RESULTS
A total of 5,366 patients were diagnosed to have cancer 
and attended to at the MTRH and other hospitals 
in Uasin Gishu district during the period between 
January 1999 to December 2006. 2,699 patients were 
males and 2,667 were females giving a M:F ratio of 
1: 1. Figure 1 shows the yearly distribution of the 
number of patients diagnosed with cancer giving an 
average of 671 cases per year. 
 There were 1,108(20.6%) patients with 
haematological malignancies. Figure 2 shows the 
different types of haematological malignancies and 
the gender distribution. Lymphomas were the most 
common (11.9%), followed by acute leukaemia 
(4.0%) and chronic leukaemia (3.2%). There were 
4,258(79.4%) patients with non-haematological 
malignancies or solid tumours. Figure 3 shows the 
different types of non-haematological malignancies 
and the gender distribution. 
Figure 1
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In all the patients with non-haematological 
malignancies, cancer of the oesophagus was the most 
common (10.5%), followed by cancer of the breast 
(6.2%) and Kaposis sarcoma (5.9%). Cancer of the 
cervix (10.0%) and prostate (5.5%) were common 
among the females and males respectively. 
DISCUSSION
Cancer management is one of the health needs which 
do not receive adequate attention from the health 
care providers and policy makers in the developing 
countries (2, 4). Most of the health care providers are ill 
prepared to effectively recognise and take appropriate 
measures when faced with cancer patients. This results 
from a combination of inadequate knowledge, poor 
attitude, lack of appropriate skills and facilities to 
manage the patients effectively (2, 4).The appalling 
poverty, poor hygiene and complex social dynamics 
contribute to the issue of affordability and accessibility 
and since the patients have to bear the cost of treatment, 
most of them initially opt to utilise alternative and 
traditional systems of medicine and when these have 
failed, they eventually end up in the appropriate 
health institutions with late stage incurable disease 
whereby the only option is palliative care (3, 4). 
 The findings of the study show an increase in the 
number of patients attended to at MTRH and other 
hospitals in Uasin Gishu district from 1999 to 2004 
and then a slight decline in 2005 and 2006 (Figure 1). 
The possible reasons for the increase in the number 
of cases include the establishment of a functional 
oncology service which encouraged the referral of 
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that improved record keeping. The decline could be 
due to the establishment of an outreach oncology 
service based at five distant sites in a radius of about 
150 km from Eldoret in 2005. A significant number 
of patients are seen at the satellite sites without ever 
coming to MTRH. The oncology services at these 
sites are integrated with the comprehensive care 
programme run by the Academic Model for the 
Prevention and Treatment of HIV/AIDS (AMPATH). 
The apparent success of the outreach services has 
opened up a significant opportunity of realising the 
desire to effectively serve the rural poor who are 
not able to access centralized services far away from 
them. 
 Among the haematological malignancies, the 
lymphomas were the most common (11.9%) followed 
by the acute leukemia (4.0%). Similar to occurrences 
elsewhere, these malignancies are commonly seen in 
the young population. The chronic leukemia (3.2%) 
is seen in the older population. 
 Among the solid tumours cancer of the 
oesophagus (10.5%), cervix (7.9%), breast (6.2%), 
Kaposis sarcoma (5.9%) and prostrate (4.4%) were the 
most common. These results are similar to findings of 
studies done elsewhere in Africa. The good news for 
this region is that most of these cancers are curable 
if detected early and treated appropriately (4, 6). 
Majority of these cancers are also preventable hence 
correct application of available information could 
prevent up to a third of the cases (1, 2,5,7,8). A well 
organised oncology service can therefore make a 
major positive change. 
 There is a significant increase in the number of 
patients accessing care both within the MTRH and 
at the satellite clinics yet the oncology services still 
face serious challenges. This is a resource constraint 
region with few health care providers to serve the large 
population, chemotherapeutic drugs are expensive 
and radiotherapy is yet to be established. Negative 
believes and attitudes still play a significant role in 
influencing the accessibility of health services. These 
are among the challenges to contend with and like 
most of the other resource constrained regions it looks 
forward to benefiting from the global initiatives to 
fight cancer (3, 9). 
 Development of a comprehensive oncology/
cancer care programme is necessary to promote 
effective management of patients with cancer in 
western Kenya. The first role of the programme 
should be to sensitise the relevant authorities on 
the position of the oncology services in raising the 
well being of the population. There is also a need 
for inclusion of information on cancer management 
in training curricular for health care professionals. 
The programme should be able to support the 
management of patients through strengthening the 
already existing national hospital insurance fund 
(NHIF), donations and research activities. Other 
necessary measures include proper record keeping 
through creation of an oncology database, enhancing 
screening activities, development and use of treatment 
protocols suitable for resource limited settings, 
establishment of radiotherapy services and proper 
coordination between various disciplines involved in 
cancer care. As part of the efforts to work with others 
committed to fighting cancer, a collaboration between 
MTRH (Kenya), Moi University School of Medicine 
(Kenya), Indiana University (USA), Brown University 
(USA) and Oregon university (USA) has been set up 
to put in motion the above recommendations. More 
local stakeholders need to come on board to boost 
these efforts. 
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